Membrane type 1-matrix metalloproteinase expression is regulated by E- cadherin through the suppression of mitogen-activated protein kinase cascade

Cancer Letters

Volumn 157, Issue 2, 2000, Pages 115-121

  Ara, Toshiaki ^a   Deyama, Yoshiaki ^a   Yoshimura, Yoshitaka ^a   Higashino, Fumihiro ^a   Shindoh, Masanobu ^a   Matsumoto, Akira ^a   Fukuda, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

E cadherin; Membrane type 1 matrix metalloproteinase; Mitogen activated protein kinase cascade; Squamous carcinoma cell line

Indexed keywords

ALPHA CATENIN; BETA CATENIN; COLLAGENASE; COMPLEMENTARY DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UVOMORULIN;

ACTIN FILAMENT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL POLARITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONGUE CARCINOMA;

ALPHA CATENIN; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CYTOSKELETAL PROTEINS; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASES; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034285099     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00494-8     Document Type: Article

References (26)

1. Kawahara E., Okada Y., Nakanishi I., Iwata K., Kojima S., Kumagai S., Yamamoto E. The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn. J. Cancer Res. 84:1993;409-418.
2. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251:1991;1451-1455.
3. Schipper J.H., Frixen U.H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51:1991;6328-6337.
4. Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., Abe O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 49:1989;2128-2133.
5. Moll R., Mitze M., Frixen U.H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 143:1993;1731-1742.
6. Becker K.F., Atkinson M.J., Reich U., Huang H.H., Nekarda H., Siewert J.R., Hofler H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Mol. Genet. 2:1993;803-804.
7. Oda T., Kanai Y., Oyama T., Yoshiura K., Shimoyama Y., Birchmeier W., Sugimura T., Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA. 91:1994;1858-1862.
8. Kanai Y., Oda T., Tsuda H., Ochiai A., Hirohashi S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn. J. Cancer Res. 85:1994;1035-1039.
9. Polette M., Gilles C., de Bentzmann S., Gruenert D., Tournier J.M., Birembaut P. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines. Clin. Exp. Metastasis. 16:1998;105-112.
10. Kitadai Y., Ellis L.M., Tucker S.L., Greene G.F., Bucana C.D., Cleary K.R., Takahashi Y., Tahara E., Fidler I.J. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am. J. Pathol. 149:1996;1541-1551.
11. Miyaki M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Konishi M., Takeichi M. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. Oncogene. 11:1995;2547-2552.
12. Borchers A.H., Sanders L.A., Bowden G.T. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J. Cancer Res. Clin. Oncol. 123:1997;13-20.
13. Llorens A., Rodrigo I., Lopez-Barcons L., Gonzalez-Garrigues M., Lozano E., Vinyals A., Quintanilla M., Cano A., Fabra A. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab. Invest. 78:1998;1131-1142.
14. Easty D.M., Easty G.C., Carter R.L., Monaghan P., Butler L.J. Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck. Br. J. Cancer. 43:1981;772-785.
15. Sambrook J., Fritsch E.F., Maniatis T. Expression of cloned genes in cultured mammalian cells. Nina I. Molecular Cloning: a Laboratory Manual. 2nd Edition :1989;16.54-16.55 Cold Spring Harbor Laboratory Press, New York.
16. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:1980;196-202.
17. Sato H., Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. 119:1996;209-215.
18. Kolkenbrock H., Orgel D., Hecker-Kia A., Noack W., Ulbrich N. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198:1991;775-781.
19. Habelhah H., Okada F., Kobayashi M., Nakai K., Choi S., Hamada J., Moriuchi T., Kaya M., Yoshida K., Fujinaga K., Hosokawa M. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene. 18:1999;1771-1776.
20. Rabault B., Roussel M.F., Quang C.T., Ghysdael J. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene. 13:1996;877-881.
21. Kadono Y., Shibahara K., Namiki M., Watanabe Y., Seiki M., Sato H. Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-darby canine kidney epithelial cells. Biochem. Biophys. Res. Commun. 251:1998;681-687.
22. Frixen U.H., Nagamine Y. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res. 53:1993;3618-3623.
23. Botteri F.M., Ballmer-Hofer K., Rajput B., Nagamine Y. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression. J. Biol. Chem. 265:1990;13327-13334.
24. Tomasek J.J., Halliday N.L., Updike D.L., Ahern-Moore J.S., Vu T.K., Liu R.W., Howard E.W. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272:1997;7482-7487.
25. Aghib D.F., McCrea P.D. The E-cadherin complex contains the src substrate p120. Exp. Cell Res. 218:1995;359-369.
26. Doki Y., Shiozaki H., Tahara H., Inoue M., Oka H., Iihara K., Kadowaki T., Takeichi M., Mori T. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res. 53:1993;3421-3426.